Mercado de irradiación de sangre: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00003256
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 170
Buy Now

Se prevé que el mercado de irradiación de sangre alcance los 104,37 millones de dólares en 2028, frente a los 65,15 millones de dólares de 2021; se espera que crezca a una tasa compuesta anual del 7,0% de 2022 a 2028.

La creciente prevalencia de trastornos transmisibles y no transmisibles y el aumento de la investigación y el desarrollo impulsan el crecimiento del mercado. Sin embargo, el alto costo de la irradiación de la sangre restringe el crecimiento del mercado.

La irradiación de la sangre se logra exponiendo la sangre a al menos 25 Gy (2500 cGy) de radiación en el centro del vaso, evitando la replicación y injerto de leucocitos T del donante inmunológicamente competentes al receptor. La GvHD causada por trasplantes de donantes casi siempre es fatal, por lo que los pacientes en riesgo deben recibir productos sanguíneos irradiados según lo permitan el tiempo y los recursos. Las indicaciones clínicas, incluidas la leucemia aguda, el linfoma, los tumores sólidos que reciben quimioterapia o radioterapia intensiva, las exanguinotransfusiones, los receptores de trasplantes de órganos y los bebés prematuros, requieren terapia de irradiación sanguínea. Los pacientes afectados por el virus de la inmunodeficiencia humana/síndrome de inmunodeficiencia adquirida no requieren irradiación de productos sanguíneos ya que no se ha informado que sean susceptibles a la enfermedad de injerto a huésped post-transfusión.

Perspectivas estratégicas

< h3>regiones lucrativas para el mercado de irradiación de sangre

Perspectivas del mercado

El aumento de la prevalencia de enfermedades transmisibles y no transmisibles impulsa el crecimiento del mercado

Allí Hay un aumento en el número de incidencia de enfermedades transmisibles y no transmisibles, incluidos cáncer, trastornos cardiovasculares, enfermedades renales crónicas y accidentes cerebrovasculares, debido a una gran población en todo el mundo susceptible a tales afecciones. Según la Organización Mundial de la Salud (OMS), los trastornos cardiovasculares son la principal causa de muerte en todo el mundo y cada año se notifican ~17,9 millones de muertes. Además, la creciente prevalencia de enfermedades transmisibles, como la hepatitis, la influenza, el virus de la inmunodeficiencia humana (VIH) y el síndrome de inmunodeficiencia adquirida (SIDA), están impulsando el crecimiento del mercado de irradiación sanguínea. Según la OMS, 325 millones de personas se infectaron con el virus de la hepatitis B en 2020 y 900.000 personas mueren cada año a causa de la infección por el virus de la hepatitis B. Además, una gran población geriátrica en todo el mundo está contribuyendo a la prevalencia de enfermedades no transmisibles, como trastornos cardiovasculares, trastornos renales y accidentes cerebrovasculares. Según la OMS, la población de personas de 60 años o más era de 1.000 millones en 2019 y se espera que aumente a 1.400 millones en 2030 y a 2.100 millones en 2050. La población de edad avanzada es susceptible a enfermedades no transmisibles debido a diversos factores, como la pobreza. nutrición, falta de actividad física, uso excesivo de tabaco y consumo de alcohol.

Además, el aumento de las transfusiones de sangre debido al aumento de procedimientos quirúrgicos, accidentes, casos de trauma y trastornos, junto con la creciente prevalencia de infecciones del torrente sanguíneo, apoya el crecimiento del mercado. Las infecciones del torrente sanguíneo, las afecciones subyacentes y los procedimientos invasivos son comunes entre la población geriátrica. Las infecciones del torrente sanguíneo son la principal causa de enfermedad y muerte entre grandes poblaciones. Según la Biblioteca Nacional de Medicina, cada año se producen alrededor de 28.000 infecciones del torrente sanguíneo en todo el mundo. Además, la creciente conciencia sobre las infecciones del torrente sanguíneo y el aumento de las respuestas inmunitarias a la sangre transfundida pueden causar complicaciones, ya que el creciente uso de sangre irradiada en el tratamiento del cáncer fortalece el sistema inmunológico y mejora la salud general de los pacientes, lo que está impulsando el crecimiento del mercado de la irradiación de sangre. p>

Por lo tanto, el aumento de la prevalencia de trastornos transmisibles y no transmisibles, el aumento de las transfusiones de sangre, el aumento de las infecciones del torrente sanguíneo y el aumento de las respuestas inmunitarias están impulsando el crecimiento del mercado de irradiación de sangre.

Información basada en el tipo

El mercado de irradiación de sangre, según el tipo, se segmenta en irradiación de sangre con láser intravenoso, irradiación de sangre con láser transcutáneo e irradiación de sangre extracorpórea. En 2021, el segmento de irradiación sanguínea con láser intravenoso representó la mayor cuota de mercado. Sin embargo, se espera que el segmento de irradiación sanguínea con láser extracorpóreo registre la CAGR más alta del 7,8% durante el período de pronóstico.

Información basada en el usuario final

Según el usuario final, el mercado de irradiación de sangre se segmenta en hospitales, bancos de sangre, clínicas de diagnóstico e institutos de investigación. El segmento de hospitales tuvo la mayor participación de mercado en 2021. Sin embargo, se estima que el segmento de bancos de sangre registrará la CAGR más alta del mercado del 7,7% durante el período de pronóstico.

Información basada en indicaciones

Por indicación, el mercado de irradiación sanguínea se segmenta en leucemia aguda, tumores sólidos, tumores pélvicos, linfoma y otros. El segmento de leucemia aguda tuvo la mayor participación de mercado en 2021. Sin embargo, se estima que el segmento de linfoma registrará la CAGR más alta del mercado del 8,8% durante el período de pronóstico.

Mercado de irradiación de sangre, por tipo: 8,8% en el mercado durante el período de pronóstico. 2021 y 2028

Las empresas que operan en el mercado de irradiación de sangre adoptan la estrategia de innovación de productos para satisfacer las demandas cambiantes de los clientes en todo el mundo, que también les permite mantener su marca en el mercado global. Por ejemplo, en junio de 2021, Rad Source Technologies, un proveedor comercial de productos de radiación de rayos X en EE. UU., diseñó un producto para reemplazar los irradiadores gamma autoprotegidos y presentó su irradiador de sangre RS 3400 recientemente rediseñado en MEDLAB Middle East 2021.

Mercado de irradiación de sangre - ndash; por geografía

Geográficamente, el mercado de irradiación de sangre está segmentado en América del Norte (EE. UU., Canadá y México), Europa (Francia, Alemania, Reino Unido, España, Italia y el resto de Europa), Asia Pacífico (China, India, Japón, Australia, Corea del Sur y el resto de Asia Pacífico), Medio Oriente y Asia. África (Arabia Saudita, Emiratos Árabes Unidos, Sudáfrica y el resto de Oriente Medio y África) y Sudáfrica y África. Centroamérica (Brasil, Argentina y resto de Centro y Suramérica). Typenex médico, LLC; Sistemas médicos Hitachi; Tecnologías de fuentes radiactivas; Gilardoni SpA; Gamma-Service Medical GmbH; Actemium; y Best Theratronics Ltd. se encuentran entre los participantes del mercado incluidos en el estudio de investigación.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is meant by the blood irradiation market?

Blood irradiation is the process in which blood is exposed to low level of radiation which deactivates the T lymphocytes and inhibits the immune response for the prevention of rare graft-versus-host disease (GVHD). This therapy is also used for the treatment of various disorders such as autoimmune disorders, cancer, neuropathies and many more.

What are the driving factors for the blood irradiation market across the globe?

Increase in communicable and non-communicable diseases, rise in healthcare expenditure, and government initiatives are the most significant factors responsible for the overall market growth.

Which segment led the blood irradiation market?

Based on type, intravenous laser blood irradiation took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which indication segment held the largest revenue (US$ Mn) in the blood irradiation market?

The acute leukemia segment dominated the global blood irradiation market and accounted for the largest revenue of 26.93 Mn in 2021.

Who are the key players in the blood irradiation market?

Typenex Medical, LLC; Hitachi Medical Systems; Rad Source Technologies; Gilardoni S.p.A.; Gamma-Service Medical GmbH; Actemium; Best Theratronics Ltd. are among the leading companies operating in the global blood irradiation market

What is the regional market scenario of the blood irradiation market?

Global blood irradiation market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the U.S. held the largest market share for blood irradiation market. The US is estimated to hold the largest share in the blood irradiation market during the forecast period. Increase in R&D activities along with surge in autoimmune disorders and organ transplants are the contributing factors for the regional growth. Additionally, increase in communicable and non-communicable diseases is the key factor responsible for the Asia-Pacific regional growth for blood irradiation accounting fastest growth of the region during the coming years.

The List of Companies - Blood Irradiation Market

  1. Typenex Medical, LLC
  2. Hitachi Medical Systems
  3. Rad Source Technologies
  4. Gilardoni S.p.A.
  5. Gamma-Service Medical GmbH
  6. Actemium
  7. Best Theratronics Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports